Mutated epigenetic modifiers in CYLD cutaneous syndrome

被引：0
|
作者：
Davies, H. R. [1 ]
Hodgson, K. [2 ]
Schwalbe, E. [3 ]
Coxhead, J. [2 ]
Sinclair, N. [2 ]
Zou, X. [4 ]
Cockell, S. [2 ]
Husain, A. [5 ]
Nik-Zainal, S. [6 ]
Rajan, N. [2 ]
机构：
[1] Wellcome Trust Sanger Inst, Hinxton, England
[2] Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England
[3] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England
[4] MRC Canc Unit, Cambridge, England
[5] Royal Victoria Infirm, Dept Pathol, Newcastle Upon Tyne, Tyne & Wear, England
[6] Acad Dept Med Genet, Cambridge, England
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
基金：
英国惠康基金;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
C27.3
引用
收藏
页码：1164 / 1164
页数：1
相关论文
共 50 条
  • [1] Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
    Davies, Helen R.
    Hodgson, Kirsty
    Schwalbe, Edward
    Coxhead, Jonathan
    Sinclair, Naomi
    Zou, Xueqing
    Cockell, Simon
    Husain, Akhtar
    Nik-Zainal, Serena
    Rajan, Neil
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [2] Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
    Helen R. Davies
    Kirsty Hodgson
    Edward Schwalbe
    Jonathan Coxhead
    Naomi Sinclair
    Xueqing Zou
    Simon Cockell
    Akhtar Husain
    Serena Nik-Zainal
    Neil Rajan
    Nature Communications, 10
  • [3] Pulmonary cylindromas in CYLD cutaneous syndrome
    Brown, S.
    Barnard, S.
    Langtry, J.
    Worthy, S. A.
    Bloxham, C.
    Loo, P. S.
    Husain, A.
    Rajan, N.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 56 - 57
  • [4] DNMT3A is an epigenetic negative regulator of Wnt/β-catenin pathway signalling in CYLD cutaneous syndrome
    Hodgson, K.
    Davies, H.
    Schwalbe, E.
    Coxhead, J.
    Sinclair, N.
    Zou, X.
    Cockell, S.
    Husain, A.
    Nik-Zainal, S.
    Rajan, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S262 - S262
  • [5] Genetic Testing in CYLD Cutaneous Syndrome: An Update
    Nagy, Nikoletta
    Dubois, Anna
    Szell, Marta
    Rajan, Neil
    APPLICATION OF CLINICAL GENETICS, 2021, 14 : 427 - 444
  • [6] Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome
    Mian, Syed A.
    Smith, Alexander E.
    Kulasekararaj, Austin G.
    Kizilors, Aytug
    Mohamedali, Azim M.
    Lea, Nicholas C.
    Mitsopoulos, Konstantinos
    Ford, Kevin
    Nasser, Erick
    Seidl, Thomas
    Mufti, Ghulam J.
    HAEMATOLOGICA, 2013, 98 (07) : 1058 - 1066
  • [7] A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family
    Zhu, Ruizheng
    Xu, Jie
    Shen, Juan
    Li, Wenru
    Tan, Fei
    Li, Changchang
    Wei, Zhichen
    Liu, Yeqiang
    Bai, Yun
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (10):
  • [8] A mosaic contiguous deletion associated with CYLD cutaneous syndrome
    Arefi, M.
    Zwolinski, S.
    Bown, N.
    Wilson, V.
    Rajan, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S135 - S135
  • [9] Persistence of Mutated Epigenetic Modifiers During Morphologic Remission of AML with Mutated NPM1
    Soderquist, Craig
    Velu, Priya
    Frank, Dale
    MODERN PATHOLOGY, 2018, 31 : 555 - 555
  • [10] Persistence of Mutated Epigenetic Modifiers During Morphologic Remission of AML with Mutated NPM1
    Soderquist, Craig
    Velu, Priya
    Frank, Dale
    LABORATORY INVESTIGATION, 2018, 98 : 555 - 555
12345